Shawn Yu

ORCID: 0000-0003-1951-2949

Also affiliated with Applied Materials (United States), Chinese PLA General Hospital, Abbott (United Kingdom), Chinese General Hospital College of Nursing and Liberal Arts, First People's Hospital of Chongqing

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “A Pilot Study of Pembrolizumab in Combination With Y90 Radioembolization in Subjects With Poor Prognosis Hepatocellular Carcinoma”.

A Pilot Study of Pembrolizumab in Combination With Y90 Radioembolization in Subjects With Poor Prognosis Hepatocellular Carcinoma

The Oncologist(2024)10.1093/oncolo/oyad331

N/A

1.4DataRank · unranked

46 citations

Menggang Yu, Barry Keane, David Mauro, Paul R. Helft, William Proctor Harris +6 more

A Pilot Study of Pembrolizumab in Combination With Y90 Radioembolization in Subjects With Poor Prognosis Hepatocellular Carcinoma

UNC Libraries(2024)10.17615/7zap-4733

N/A

0DataRank · unranked

0 citations

Barry Keane, David Mauro, Menggang Yu, Bert H. O’Neil, Paul R. Helft +6 more